ResMed (RMD) Stock: Buy, Sell, or Hold?
RMD - ResMed Inc.
$217.64
-1.94 (-0.88%)
▼
5d:
-5.04%
30d:
-3.7%
90d:
+13.12%
WAIT
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Oct 29, 2026
Get Alerted When RMD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: RMD shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: RMD shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$313.04
Based on 6.3% avg growth
INTRINSIC VALUE TODAY
$194.38
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 19.1x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: RMD is currently trading at $217.64, which is considered oversold relative to its 30-day fair value range of $219.39 to $233.68. The stock's valuation (Forward PE: 18.2) is in line with its historical norms (19.1). Remarkably, the market is currently pricing in an annual earnings decline of 1.7% over the next few years. This pessimistic expectation contrasts with the company's recent 2.4% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, RMD is in a uptrend. The price is currently testing key support at $215.80. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: RMD scores 17/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $246.12 (+12.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, RMD is in a uptrend. The price is currently testing key support at $215.80. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: RMD scores 17/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $246.12 (+12.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$219.39 -
$233.68
Company Quality Score
41/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
63.5%
Protect Your Profits
Holding RMD? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 0th percentile)
- BEARISH: Weak technical setup (17/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($246.12)
- WARNING: Composite score 41/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$219.39 -
$233.68
Current vs Trading Range
OVERSOLD
Expected Move (7 Days)
±$8.20
(3.8%)
Support & Resistance Levels
Support Level
$215.80
Resistance Level
$242.40
Current Trend
Uptrend
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
18.17
Wall Street Target
$246.13
(+12.1%)
Revenue Growth (YoY)
8.6%
Earnings Growth (YoY)
2.4%
Profit Margin
27.0%
Valuation Discount vs History
-1.7% cheaper
PE vs Historical
18.2 vs 19.1
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-1.7%
(market-implied from PE analysis)
1-Year Target
$215.85
(-2%)
2-Year Target
$212.18
(-3%)
3-Year Target
$208.57
(-5%)
3-Yr Target (if PE normalizes)
(PE: 18→19)
$219.21
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.2, Growth: 8.6%)
$312.37
(+42%)
Base:
(SPY PE: 18.2, Growth: 8.6%)
$281.45
(+28%)
Bear:
(PE: 15.4, Growth: 8.6%)
$239.23
(+9%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (21x PE), but valuation improves significantly next year (18x PE) as earnings recover.
Trailing PE: 21.19 | Current EPS (TTM): $10.38
Bull Case
$281.63
(+28%)
Analyst growth 16.4%, PE expands to 23.3
Base Case
$256.03
(+17%)
Market implied 16.4%, PE stable at 21.2
Bear Case
$149.57
(-32%)
Severe decline -20.0%, PE contracts to 18.0
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 18.2 to 19.1
Stabilization Target:
$230.78
(+5.1%)
PE Expansion Potential:
+5.1%
Share & Embed Analysis
Last updated: September 11, 2026 1:40 PM ET
Data refreshes hourly during market hours. Next update: 2:40 PM
Data refreshes hourly during market hours. Next update: 2:40 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is RMD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
4
Sells
Net
INSIDERS SELLING
Recent Transactions
Michael J Farrell
SELL
4991 shares
2026-04-07
Peter C Farrell
SELL
2000 shares
2026-04-01
Ro Khanna
SELL
2026-03-30
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$478 | 53 HOLD |
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$85 | 35 SELL |
|
WST
West Pharmaceutical Serv… |
STRONG BUY
13 analysts |
$405 | 63 BUY |
|
RGEN
Repligen Corporation |
STRONG BUY
19 analysts |
$188 | 45 HOLD |
|
COO
The Cooper Companies, Inc |
BUY
19 analysts |
$82 | 43 HOLD |
Advanced RMD Option Strategies
Professional options setups generated by AI based on today's RMD price and gamma walls.
